Oxford Lane Capital Corp. Prices Preferred Stock Offering

The financing adds to the existing 8.25% preferred series, with an option for underwriters to purchase additional shares.

Rhea-AI Summary

Oxford Lane Capital (OXLC) priced an underwritten public offering of additional preferred shares for $35,784,000 in gross proceeds.

The offering comprises 1,440,000 shares of its 8.25% Series 2031 Term Preferred Shares at $24.85 per share. Underwriters have a 30-day option to purchase up to 216,000 additional shares to cover over-allotments. The new shares will form a single series with the existing preferred stock, listed as OXLCM, bringing that series to 4,200,000 shares outstanding upon issuance. The company expects delivery on October 23, 2026, subject to customary closing conditions, and plans to use net proceeds to repay outstanding indebtedness and/or for general working capital.

1 point · 0 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate point. Forward-looking: it has not happened yet and may not happen.Offering priced for $35,784,000 in gross proceeds, providing additional financing upon completion. 5.1% of market cap

Negative

• Moderate point. Forward-looking: it has not happened yet and may not happen.Issuance of 1,440,000 preferred shares at $24.85 each expands the company's 8.25% preferred-stock obligations.
• Minor point. Forward-looking: it has not happened yet and may not happen.Underwriters' 30-day option for up to 216,000 additional preferred shares could further expand preferred-stock obligations.

Key Figures

Shares offered: 1,440,000 shares Offering price: $24.85 per share Gross proceeds: $35,784,000 +5 more

Shares offered

1,440,000 shares

Additional 8.25% Series 2031 Term Preferred Shares

Offering price

$24.85 per share

Public offering

Gross proceeds

$35,784,000

Offering proceeds before expenses

Preferred stock rate

8.25%

Series 2031 Term Preferred Shares

Over-allotment option

Up to 216,000 additional shares

Same terms and conditions

Option period

30 days

Underwriters' option to purchase additional shares

Shares outstanding after issuance

4,200,000 shares

8.25% Series 2031 Term Preferred Shares

Expected delivery

October 23, 2026

Subject to customary closing conditions

Key Terms

over-allotments, cusip, shelf registration statement, prospectus supplement

4 terms

over-allotments financial

"to cover over-allotments, if any"

An over-allotment is a temporary extra batch of shares that the underwriters of a stock offering are allowed to sell beyond the original amount, with the right to buy those shares back later. Think of it as spare tickets sold to meet demand and then reclaimed if needed to keep the market orderly; it helps stabilize the stock price after an offering and can affect short-term supply and potential dilution, which matters to investors tracking price and ownership stakes.

cusip technical

"will have the same CUSIP as the Existing Preferred Stock"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

View in glossary

shelf registration statement regulatory

"A shelf registration statement relating to these securities is on file"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

prospectus supplement regulatory

"a prospectus and a related prospectus supplement"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GREENWICH, Conn., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq GS: OXLC, OXLCL, OXLCO, OXLCZ, OXLCN, OXLCI, OXLCG and OXLCM) (the “Company”) today announced that it has priced an underwritten public offering of an additional 1,440,000 shares of its 8.25% Series 2031 Term Preferred Shares (the “Preferred Stock”) at a public offering price of $24.85 per share, raising $35,784,000 in gross proceeds. The Company has also granted the underwriters a 30-day option to purchase up to 216,000 additional shares of Preferred Stock on the same terms and conditions to cover over-allotments, if any. The Preferred Stock is a further issuance of the Company’s 8.25% Series 2031 Term Preferred Shares, which the Company issued on March 20, 2026 (the “Existing Preferred Stock”). The Preferred Stock will be treated as a single series with the Existing Preferred Stock and will have the same terms as the Existing Preferred Stock. The Preferred Stock will have the same CUSIP as the Existing Preferred Stock. Upon the issuance of the Preferred Stock, there will be 4,200,000 8.25% Series 2031 Term Preferred Shares outstanding. The closing of the transaction is subject to customary closing conditions, and the shares are expected to be delivered on October 23, 2026. The 8.25% Series 2031 Term Preferred Stock is listed on the NASDAQ Global Select Market under the symbol “OXLCM.”

The Company expects to use the net proceeds from this offering to repay outstanding indebtedness and/or for general working capital purposes.

Piper Sandler & Co. and Lucid Capital Markets, LLC are acting as joint book-running managers for the offering and A.G.P./Alliance Global Partners and InspereX LLC are acting as lead managers for the offering.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities in this offering or any other securities nor will there be any sale of these securities or any other securities referred to in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

A shelf registration statement relating to these securities is on file with the Securities and Exchange Commission and is effective. The offering of the Preferred Stock may be made only by means of a prospectus and a related prospectus supplement, copies of which may be obtained, when available, from the following investment banks: Piper Sandler & Co., Attn: Debt Capital Markets, 1251 Avenue of the Americas, 6th Floor, New York, NY 10020 or by e-mailing fsg-dcm@psc.com; Lucid Capital Markets, LLC, 570 Lexington Ave, 40th Floor, New York, NY 10022 or by telephone number (646) 362-0256. The preliminary prospectus supplement, dated October 21, 2026, and accompanying prospectus, dated November 8, 2024, each of which has been filed with the Securities and Exchange Commission, contain a description of these matters and other important information about the Company and should be read carefully before investing. Investors are advised to carefully consider the investment objectives, risks and charges and expenses of the Company before investing.

About Oxford Lane Capital Corp.

Oxford Lane Capital Corp. is a publicly-traded registered closed-end management investment company principally investing in debt and equity tranches of collateralized loan obligation (“CLO”) vehicles. CLO investments may also include warehouse facilities, which are financing structures intended to aggregate loans that may be used to form the basis of a CLO vehicle.

Forward-Looking Statements

This press release contains forward-looking statements subject to the inherent uncertainties in predicting future results and conditions, including statements with regard to the anticipated use of the net proceeds of the Company’s offering of the Preferred Stock. Any statements that are not statements of historical fact (including statements containing the words “believes,” “plans,” “anticipates,” “expects,” “estimates” and similar expressions) should also be considered to be forward-looking statements. These statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Certain factors could cause actual results and conditions to differ materially from those projected in these forward-looking statements. These factors are identified from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update such statements to reflect subsequent events, except as may be required by law.

Contact:
Bruce Rubin
203-983-5280

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the terms of Oxford Lane Capital's preferred stock offering?

Oxford Lane Capital priced 1,440,000 additional 8.25% Series 2031 Term Preferred Shares at $24.85 per share, for $35,784,000 in gross proceeds. The shares will have the same terms as the existing series, which trades under OXLCM.

When will Oxford Lane Capital's preferred offering shares be delivered?

Oxford Lane Capital expects the preferred shares to be delivered on October 23, 2026. Closing remains subject to customary closing conditions.